Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells

Gerald M. Segal, R. Ellen Magenis, Michael Brown, Winifred Keeble, Tamara D. Smith, Michael Heinrich, Grover C. Bagby

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Bone marrow failure is a consistent feature of Fanconi anemia (FA) but it is not known whether the bone marrow failure is a direct and specific result of the inherited mutation or a consequence of accumulated stem cell losses resulting from nonspecific DNA damage. We tested the hypothesis that the protein encoded by the FA group C complementing gene (FACC) plays a regulatory role in hematopoiesis. We exposed normal human lymphocytes, bone marrow cells, endothelial cells, and fibroblasts to an antisense oligodeoxynucleotide (ODN) complementary to bases -4 to +14 of FACC mRNA. The mitomycin C assay demonstrated that the antisense ODN, but not missense or sense ODNs, repressed FACC gene expression in lymphocytes. Treatment with the antisense ODN substantially reduced, in a sequence-specific fashion, cytoplasmic levels of FACC mRNA in bone marrow cells and lymphocytes. Escalating doses of antisense ODN increasingly inhibited clonal growth of erythroid and granulocyte-macrophage progenitor cells but did not inhibit growth of fibroblasts or endothelial cells. The antisense ODN did not inhibit growth factor gene expression by low density bone marrow cells or marrow- derived fibroblasts. We conclude that, while the FACC gene product plays a role in defining cellular tolerance to cross-linking agents, it also functions to regulate growth, differentiation, and/or survival of normal hematopoietic progenitor cells.

Original languageEnglish (US)
Pages (from-to)846-852
Number of pages7
JournalJournal of Clinical Investigation
Volume94
Issue number2
StatePublished - Aug 1994
Externally publishedYes

Fingerprint

Fanconi Anemia
Hematopoietic Stem Cells
Oligodeoxyribonucleotides
Gene Expression
Growth
Bone Marrow Cells
Genes
Fibroblasts
Bone Marrow
Lymphocytes
Fanconi Anemia Complementation Group C Protein
Endothelial Cells
Messenger RNA
Granulocyte-Macrophage Progenitor Cells
Hematopoiesis
Mitomycin
DNA Damage
Intercellular Signaling Peptides and Proteins
Stem Cells
Mutation

Keywords

  • antisense oligonucleotides
  • chromosome instability
  • cross-linking agent
  • DNA damage
  • hematopoiesis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. / Segal, Gerald M.; Magenis, R. Ellen; Brown, Michael; Keeble, Winifred; Smith, Tamara D.; Heinrich, Michael; Bagby, Grover C.

In: Journal of Clinical Investigation, Vol. 94, No. 2, 08.1994, p. 846-852.

Research output: Contribution to journalArticle

Segal, Gerald M. ; Magenis, R. Ellen ; Brown, Michael ; Keeble, Winifred ; Smith, Tamara D. ; Heinrich, Michael ; Bagby, Grover C. / Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. In: Journal of Clinical Investigation. 1994 ; Vol. 94, No. 2. pp. 846-852.
@article{8b530b11bbda4ac282900825bbf39418,
title = "Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells",
abstract = "Bone marrow failure is a consistent feature of Fanconi anemia (FA) but it is not known whether the bone marrow failure is a direct and specific result of the inherited mutation or a consequence of accumulated stem cell losses resulting from nonspecific DNA damage. We tested the hypothesis that the protein encoded by the FA group C complementing gene (FACC) plays a regulatory role in hematopoiesis. We exposed normal human lymphocytes, bone marrow cells, endothelial cells, and fibroblasts to an antisense oligodeoxynucleotide (ODN) complementary to bases -4 to +14 of FACC mRNA. The mitomycin C assay demonstrated that the antisense ODN, but not missense or sense ODNs, repressed FACC gene expression in lymphocytes. Treatment with the antisense ODN substantially reduced, in a sequence-specific fashion, cytoplasmic levels of FACC mRNA in bone marrow cells and lymphocytes. Escalating doses of antisense ODN increasingly inhibited clonal growth of erythroid and granulocyte-macrophage progenitor cells but did not inhibit growth of fibroblasts or endothelial cells. The antisense ODN did not inhibit growth factor gene expression by low density bone marrow cells or marrow- derived fibroblasts. We conclude that, while the FACC gene product plays a role in defining cellular tolerance to cross-linking agents, it also functions to regulate growth, differentiation, and/or survival of normal hematopoietic progenitor cells.",
keywords = "antisense oligonucleotides, chromosome instability, cross-linking agent, DNA damage, hematopoiesis",
author = "Segal, {Gerald M.} and Magenis, {R. Ellen} and Michael Brown and Winifred Keeble and Smith, {Tamara D.} and Michael Heinrich and Bagby, {Grover C.}",
year = "1994",
month = "8",
language = "English (US)",
volume = "94",
pages = "846--852",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells

AU - Segal, Gerald M.

AU - Magenis, R. Ellen

AU - Brown, Michael

AU - Keeble, Winifred

AU - Smith, Tamara D.

AU - Heinrich, Michael

AU - Bagby, Grover C.

PY - 1994/8

Y1 - 1994/8

N2 - Bone marrow failure is a consistent feature of Fanconi anemia (FA) but it is not known whether the bone marrow failure is a direct and specific result of the inherited mutation or a consequence of accumulated stem cell losses resulting from nonspecific DNA damage. We tested the hypothesis that the protein encoded by the FA group C complementing gene (FACC) plays a regulatory role in hematopoiesis. We exposed normal human lymphocytes, bone marrow cells, endothelial cells, and fibroblasts to an antisense oligodeoxynucleotide (ODN) complementary to bases -4 to +14 of FACC mRNA. The mitomycin C assay demonstrated that the antisense ODN, but not missense or sense ODNs, repressed FACC gene expression in lymphocytes. Treatment with the antisense ODN substantially reduced, in a sequence-specific fashion, cytoplasmic levels of FACC mRNA in bone marrow cells and lymphocytes. Escalating doses of antisense ODN increasingly inhibited clonal growth of erythroid and granulocyte-macrophage progenitor cells but did not inhibit growth of fibroblasts or endothelial cells. The antisense ODN did not inhibit growth factor gene expression by low density bone marrow cells or marrow- derived fibroblasts. We conclude that, while the FACC gene product plays a role in defining cellular tolerance to cross-linking agents, it also functions to regulate growth, differentiation, and/or survival of normal hematopoietic progenitor cells.

AB - Bone marrow failure is a consistent feature of Fanconi anemia (FA) but it is not known whether the bone marrow failure is a direct and specific result of the inherited mutation or a consequence of accumulated stem cell losses resulting from nonspecific DNA damage. We tested the hypothesis that the protein encoded by the FA group C complementing gene (FACC) plays a regulatory role in hematopoiesis. We exposed normal human lymphocytes, bone marrow cells, endothelial cells, and fibroblasts to an antisense oligodeoxynucleotide (ODN) complementary to bases -4 to +14 of FACC mRNA. The mitomycin C assay demonstrated that the antisense ODN, but not missense or sense ODNs, repressed FACC gene expression in lymphocytes. Treatment with the antisense ODN substantially reduced, in a sequence-specific fashion, cytoplasmic levels of FACC mRNA in bone marrow cells and lymphocytes. Escalating doses of antisense ODN increasingly inhibited clonal growth of erythroid and granulocyte-macrophage progenitor cells but did not inhibit growth of fibroblasts or endothelial cells. The antisense ODN did not inhibit growth factor gene expression by low density bone marrow cells or marrow- derived fibroblasts. We conclude that, while the FACC gene product plays a role in defining cellular tolerance to cross-linking agents, it also functions to regulate growth, differentiation, and/or survival of normal hematopoietic progenitor cells.

KW - antisense oligonucleotides

KW - chromosome instability

KW - cross-linking agent

KW - DNA damage

KW - hematopoiesis

UR - http://www.scopus.com/inward/record.url?scp=0027977842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027977842&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 846

EP - 852

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -